Omnipaque 350 mg/mL (Iohexol INJECTION, SOLUTION) 350 mg/mL

Omnipaque 350 mg/mL is an iodinated contrast media used for enhancing visibility during imaging procedures. This intravenous solution is designed for diagnostic imaging, including CT scans and angiography. It contains iohexol, a non-ionic contrast agent.

Strength

350 mg/mL

Pack Size

10 BOTTLE, PLASTIC in 1 BOX (0407-1414-90) / 75 mL in 1 BOTTLE, PLASTIC

Manufacturer / TM Owner

GE Healthcare

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Omnipaque 350 mg/mL is primarily used to improve the clarity of images during various diagnostic imaging procedures. It is commonly administered intravenously to enhance the visibility of blood vessels, organs, and tissues. This contrast media is often used in computed tomography (CT) scans and angiography to help healthcare professionals obtain detailed images for accurate diagnosis.

Side Effects

When administered, Omnipaque 350 mg/mL may cause a temporary warm sensation or a metallic taste in the mouth. Some individuals might experience mild nausea or a brief headache. These effects are generally short-lived and subside quickly. Severe reactions are rare but can occur, and immediate medical attention should be sought if any unusual symptoms arise.

Precautions & Warnings

Omnipaque 350 mg/mL should be used with caution in individuals with a history of allergic reactions to contrast media. It is important to inform healthcare providers about any known allergies or medical conditions before administration. Pregnant women and individuals with kidney problems should discuss the risks and benefits with their healthcare provider.

Avoid Interactions

Omnipaque 350 mg/mL may interact with certain medications, including those that affect kidney function. It is advisable to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and other substances that affect kidney function should be avoided before and after administration.

Frequently Asked Questions

Omnipaque 350 mg/mL is used as a contrast media to enhance the visibility of blood vessels, organs, and tissues during diagnostic imaging procedures such as CT scans and angiography.

Omnipaque 350 mg/mL is administered intravenously by a healthcare professional during imaging procedures.

Common side effects may include a temporary warm sensation, metallic taste, mild nausea, or a brief headache. Severe reactions are rare but require immediate medical attention.

Pregnant women should discuss the risks and benefits of using Omnipaque 350 mg/mL with their healthcare provider before administration.

Precautions include informing healthcare providers about any allergies or medical conditions, especially kidney problems, before using Omnipaque 350 mg/mL.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.